• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

控制良好的II型糖尿病患者胆固醇逆向转运异常。空腹及餐后LpA-I颗粒的研究。

Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.

作者信息

Cavallero E, Brites F, Delfly B, Nicolaïew N, Decossin C, De Geitere C, Fruchart J C, Wikinski R, Jacotot B, Castro G

机构信息

Service de Médecine Interne, Nutrition, Métabolisme Lipidique, Hôpital Henri-Mondor Créteil, France.

出版信息

Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2130-5. doi: 10.1161/01.atv.15.12.2130.

DOI:10.1161/01.atv.15.12.2130
PMID:7489233
Abstract

The high incidence and prevalence of coronary heart disease in diabetes mellitus is clearly established. The usual lipid pattern found in type II diabetic patients is a moderate increase in fasting triglyceride levels associated with low HDL cholesterol levels. These abnormalities are further amplified in the postprandial state. To study the effect of these alterations on reverse cholesterol transport, we isolated lipoprotein containing apoA-I but not apoA-II (LpA-I) particles by immunoaffinity chromatography from the plasma of well-controlled type II diabetic patients and nondiabetic matched control subjects. Different parameters involved in this antiatherogenic pathway were measured in both fasting and postprandial states. Diabetic patients had reduced levels of LpA-I particles that were protein enriched and phospholipid depleted. Gradient gel electrophoresis showed that control LpA-I particles had five distinct populations, whereas diabetic particles lacked the largest one. LpA-I isolated from diabetic plasma exhibited a decreased capacity to induce cholesterol efflux from Ob 1771 adipose cells both in fasting (15.1 +/- 10.0% versus 7.5 +/- 2.7%, P < .05) and postprandial (17.7 +/- 11.2% versus 7.7 +/- 3.9%, P < .05) states, whereas only control particles showed significantly higher ability to promote cholesterol efflux after the test meal (P = .02). Lecithin:cholesterol acyltransferase activity measured with an exogenous substrate showed a 54% increase and an 18% decrease postprandially for control subjects and patients, respectively. Thus, the different abnormalities found in the fasting state were further amplified in the postprandial situation. This resulted in LpA-I particles with aberrant size and composition and decreased ability to accomplish their antiatherogenic role in type II diabetic patients.

摘要

糖尿病患者中冠心病的高发病率和高患病率已得到明确证实。II型糖尿病患者常见的血脂模式是空腹甘油三酯水平适度升高,同时高密度脂蛋白胆固醇水平降低。这些异常在餐后状态下会进一步加剧。为了研究这些改变对逆向胆固醇转运的影响,我们通过免疫亲和色谱法从血糖控制良好的II型糖尿病患者和非糖尿病对照受试者的血浆中分离出含有载脂蛋白A-I但不含载脂蛋白A-II(LpA-I)的脂蛋白颗粒。在空腹和餐后状态下测量了这条抗动脉粥样硬化途径中涉及的不同参数。糖尿病患者的LpA-I颗粒水平降低,这些颗粒富含蛋白质且磷脂减少。梯度凝胶电泳显示,对照LpA-I颗粒有五个不同的群体,而糖尿病颗粒缺少最大的一个群体。从糖尿病血浆中分离出的LpA-I在空腹(15.1±10.0%对7.5±2.7%,P<.05)和餐后(17.7±11.2%对7.7±3.9%,P<.05)状态下诱导胆固醇从Ob 1771脂肪细胞流出的能力均降低,而只有对照颗粒在试验餐后显示出显著更高的促进胆固醇流出的能力(P=.02)。用外源性底物测量的卵磷脂胆固醇酰基转移酶活性在餐后对照受试者和患者中分别增加了54%和降低了18%。因此,空腹状态下发现的不同异常在餐后情况下进一步加剧。这导致II型糖尿病患者的LpA-I颗粒大小和组成异常,其发挥抗动脉粥样硬化作用的能力降低。

相似文献

1
Abnormal reverse cholesterol transport in controlled type II diabetic patients. Studies on fasting and postprandial LpA-I particles.控制良好的II型糖尿病患者胆固醇逆向转运异常。空腹及餐后LpA-I颗粒的研究。
Arterioscler Thromb Vasc Biol. 1995 Dec;15(12):2130-5. doi: 10.1161/01.atv.15.12.2130.
2
Abnormal capacity to induce cholesterol efflux and a new LpA-I pre-beta particle in type 2 diabetic patients.2型糖尿病患者诱导胆固醇流出的能力异常及一种新的LpA-I前β颗粒
Clin Chim Acta. 1999 Jan;279(1-2):1-14. doi: 10.1016/s0009-8981(98)00155-7.
3
Tangier disease: isolation and characterization of LpA-I, LpA-II, LpA-I: A-II and LpA-IV particles from plasma.
Biochim Biophys Acta. 1993 Aug 4;1182(1):30-6. doi: 10.1016/0925-4439(93)90149-u.
4
Cilostazol, a potent phosphodiesterase type III inhibitor, selectively increases antiatherogenic high-density lipoprotein subclass LpA-I and improves postprandial lipemia in patients with type 2 diabetes mellitus.西洛他唑是一种有效的III型磷酸二酯酶抑制剂,可选择性增加抗动脉粥样硬化的高密度脂蛋白亚类LpA-I,并改善2型糖尿病患者的餐后血脂异常。
Metabolism. 2002 Oct;51(10):1348-54. doi: 10.1053/meta.2002.35191.
5
Improved metabolic control reduces the number of postprandial apolipoprotein B-48-containing particles in type 2 diabetes.改善代谢控制可减少2型糖尿病患者餐后含载脂蛋白B-48颗粒的数量。
Atherosclerosis. 2000 Feb;148(2):283-91. doi: 10.1016/s0021-9150(99)00275-0.
6
Characterization of apoA-IV-containing lipoprotein particles isolated from human plasma and interstitial fluid.从人血浆和组织液中分离出的含载脂蛋白A-IV的脂蛋白颗粒的特性分析。
Arterioscler Thromb. 1993 Jan;13(1):126-32. doi: 10.1161/01.atv.13.1.126.
7
Biochemical characterization of the three major subclasses of lipoprotein A-I preparatively isolated from human plasma.从人血浆中制备分离出的三种主要载脂蛋白A-I亚类的生化特性
Biochemistry. 1993 Nov 23;32(46):12372-9. doi: 10.1021/bi00097a014.
8
Differential effect of subspecies of lipoprotein containing apolipoprotein A-I on cholesterol efflux from cholesterol-loaded macrophages: functional correlation with lecithin: cholesterol acyltransferase.含载脂蛋白A-I的脂蛋白亚类对胆固醇负荷巨噬细胞胆固醇流出的差异作用:与卵磷脂胆固醇酰基转移酶的功能相关性
Biochim Biophys Acta. 1992 Nov 11;1165(1):119-28. doi: 10.1016/0005-2760(92)90083-8.
9
Heterozygosity for apolipoprotein A-I(R160L)Oslo is associated with low levels of high density lipoprotein cholesterol and HDL-subclass LpA-I/A-II but normal levels of HDL-subclass LpA-I.载脂蛋白A-I(R160L)奥斯陆突变的杂合性与高密度脂蛋白胆固醇及HDL亚类LpA-I/A-II水平低下相关,但HDL亚类LpA-I水平正常。
J Lipid Res. 1997 Jan;38(1):121-31.
10
Probucol promotes reverse cholesterol transport in heterozygous familial hypercholesterolemia. Effects on apolipoprotein AI-containing lipoprotein particles.普罗布考促进杂合子家族性高胆固醇血症中的胆固醇逆向转运。对含载脂蛋白AI的脂蛋白颗粒的影响。
Atherosclerosis. 2000 Oct;152(2):433-40. doi: 10.1016/s0021-9150(99)00493-1.

引用本文的文献

1
Bridging the Gap Between the Bench and Bedside: Clinical Applications of High-density Lipoprotein Function.弥合基础与临床之间的差距:高密度脂蛋白功能的临床应用。
J Atheroscler Thromb. 2024 Sep 1;31(9):1239-1248. doi: 10.5551/jat.RV22020. Epub 2024 Jun 27.
2
High-Density Lipoprotein Alterations in Type 2 Diabetes and Obesity.2型糖尿病和肥胖症中的高密度脂蛋白改变
Metabolites. 2023 Feb 9;13(2):253. doi: 10.3390/metabo13020253.
3
HDL Functions-Current Status and Future Perspectives.高密度脂蛋白的功能——现状与未来展望。
Biomolecules. 2023 Jan 4;13(1):105. doi: 10.3390/biom13010105.
4
High levels of oxidized fatty acids in HDL impair the antioxidant function of HDL in patients with diabetes.高密度脂蛋白中高水平的氧化脂肪酸会损害糖尿病患者高密度脂蛋白的抗氧化功能。
Front Endocrinol (Lausanne). 2022 Oct 20;13:993193. doi: 10.3389/fendo.2022.993193. eCollection 2022.
5
Apolipoprotein M overexpression through adeno-associated virus gene transfer improves insulin secretion and insulin sensitivity in Goto-Kakizaki rats.腺相关病毒基因转染过表达载脂蛋白 M 可改善 Goto-Kakizaki 大鼠的胰岛素分泌和胰岛素敏感性。
J Diabetes Investig. 2020 Sep;11(5):1150-1158. doi: 10.1111/jdi.13261. Epub 2020 May 9.
6
Dysfunctional HDL in diabetes mellitus and its role in the pathogenesis of cardiovascular disease.糖尿病患者功能失调的高密度脂蛋白及其在心血管疾病发病机制中的作用。
Mol Cell Biochem. 2018 Mar;440(1-2):167-187. doi: 10.1007/s11010-017-3165-z. Epub 2017 Aug 21.
7
Apolipoprotein A-II alters the proteome of human lipoproteins and enhances cholesterol efflux from ABCA1.载脂蛋白A-II改变人类脂蛋白的蛋白质组并增强ABCA1介导的胆固醇流出。
J Lipid Res. 2017 Jul;58(7):1374-1385. doi: 10.1194/jlr.M075382. Epub 2017 May 5.
8
Impaired HDL cholesterol efflux in metabolic syndrome is unrelated to glucose tolerance status: the CODAM study.代谢综合征中高密度脂蛋白胆固醇流出受损与葡萄糖耐量状态无关:CODAM研究
Sci Rep. 2016 Jun 8;6:27367. doi: 10.1038/srep27367.
9
Dysfunctional HDL and atherosclerotic cardiovascular disease.功能失调的高密度脂蛋白与动脉粥样硬化性心血管疾病。
Nat Rev Cardiol. 2016 Jan;13(1):48-60. doi: 10.1038/nrcardio.2015.124. Epub 2015 Sep 1.
10
High-Density Lipoprotein Function Measurement in Human Studies: Focus on Cholesterol Efflux Capacity.人体研究中的高密度脂蛋白功能测量:聚焦胆固醇流出能力。
Prog Cardiovasc Dis. 2015 Jul-Aug;58(1):32-40. doi: 10.1016/j.pcad.2015.05.004. Epub 2015 May 9.